Subscribe to:
POZ magazine
E-newsletters
Visit:
African American
Women
POZ Personals
Sign In / Join
Username:
Password:
 

Back to home » News & Views » Treatment News


 

November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007


emailrssprint

October 30, 2009

Common Support Schemes Failed to Increase Adherence Over the Long-Term

Programs developed to support the correct and regular dosing of antiretroviral (ARV) therapy among people living with HIV may not be as effective as experts might have hoped, according to a sobering study published online October 28 in the Journal of Acquired Immune Deficiency Syndromes. Neither peer support or pager reminders significantly boosted adherence rates in a University of Washington study conducted in Seattle.  

All of the ARVs are vulnerable to failure if drug-resistant virus emerges. In clinical studies, poor adherence is one of the primary reasons for drug resistance and treatment failure. Thus, a number of strategies have been developed over the years in hopes of improving treatment adherence. Few of these strategies have been assessed for their effectiveness.

To assess two common forms of medication dosing support, Jane Simoni, PhD, from the University of Washington, and her colleagues compared adherence rates among 224 people living with HIV participating in different support programs for three months: two-way pager reminders, peer support, reminders plus peer support and standard support.

The pager system provided reminders at the time a person’s medications needed to be taken. The peer support program consisted of one support group meeting per week, with one telephone call per week from a peer. Standard support—the usual approach to adherence counseling in HIV care—included visits with clinic staff to identify adherence barriers and strategies for overcoming obstacles.

Adherence was classified as being 100 percent adherent for seven days before completing a questionnaire. Adherence was also documented using special pill bottle caps, called electronic drug monitors (EDMs), which measure how often the medication containers were opened.

At the end of the three month intervention period, only those who received peer support were more likely to have 100 percent adherence, according to the collected EDM data. This included people who received peer support only, as well as those who received the combination of peer support and pager reminders. After the first three months, however, the positive effect of peer support began to fade, and by month six, those who received peer support were no more likely to be adherent than those who received standard support.

The people receiving only pager reminders were no more likely to have 100 percent adherence, either at three or six months, than those who received the standard support.

The authors conclude that future studies should assess specific barriers that each person living with HIV faces and, in turn, offer tailored support, rather than a one-size-fits-all approach.

NEW! Scroll down to comment on this story.

emailrssprint

  [an error occurred while processing this directive]
[Go to top]

What to do if you've just been diagnosed
Qué hacer si eres recién diagnosticado

How to find a support system
Cómo encontrar un sistema de apoyo

Things you should know before starting treatment
Cosas que deberías saber antes de comenzar un tratamiento

How to handle side effects and other concerns
Cómo tratar los efectos secundarios y otros problemas de salud

How to tell someone you have HIV/AIDS
Cómo revelar tu diagnóstico de VIH/SIDA
[an error occurred while processing this directive]
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2009 Smart + Strong. All Rights Reserved. Terms of use and Your privacy